Podcasts | Nov. 11, 2015

Anifrolumab Shows Positive Results in Lupus during Phase II Clinical Study

Anifrolumab significantly reduced disease activity as measured by several SLE composite endpoints and improved symptoms of lupus.

Podcasts | Sep. 17, 2015

Safety and Efficacy of hCDR1 (Edratide) in Patients with Active Lupus

A new analysis of data from a phase II clinical study of Edratide support the need for additional longer term studies in lupus.

Podcasts | Jul. 22, 2014

Treat-to-Target in Lupus

Treat-to-Target is a treatment approach that has been used successfully in other diseases, including rheumatoid arthritis and diabetes. An international group of lupus experts has developed a set of recommendations for using this principle in lupus.

Podcasts | Feb. 11, 2014

Hydroxycloroquine May Help Prevent APS Pregnancy Complications

Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.

Podcasts | Nov. 13, 2013

Biomarkers of Lupus Disease: Eliminating the Perplexities of Lupus Treatment Trials

Lupus Foundation of America medical director Dr. Joan Merrill discusses a recently completed a study that may help to improve the design for future lupus clinical trials and secure approval of new safe and more tolerable treatments for lupus.

Podcasts | Nov. 12, 2013

App Assists Transition from Pediatric to Adult Lupus Care

Dr. Miriam Kaufman discusses a smartphone app that helps adolescents make the transition from pediatric to adult lupus care.

Podcasts | Nov. 08, 2013

Pediatric Lupus Health-Related Quality of Life Research

Dr. Hermine Brunner of the Cincinnati Children's Hospital discusses her research on health-related quality of life in children and adolescents with lupus.

Podcasts | Nov. 07, 2013

Human Mesenchymal Stem Cells as a Potential Therapy for Lupus

Dr. Gary Gilkeson of the Medical University of South Carolina discusses his Lupus Foundation of America funded study on the potential use of human mesenchymal stem cells as a therapy for lupus.